BackNewAmsterdam Pharma Company NV - Warrants (15/11/2027) Overview

NewAmsterdam Pharma Company NV - Warrants (15/11/2027) Current Cash

NewAmsterdam Pharma Company NV - Warrants (15/11/2027)'s current cash is $420M.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$424.15M
↓ 24.78% YoYΔ $-139.71M vs prior year quarter

Peer trimmed avg / median

Loading

NewAmsterdam Pharma Company NV - Warrants (15/11/2027) Current Cash History

Loading

NewAmsterdam Pharma Company NV - Warrants (15/11/2027) vs. peers: Current Cash Comparison

Loading

NewAmsterdam Pharma Company NV - Warrants (15/11/2027) Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

NewAmsterdam Pharma Company NV - Warrants (15/11/2027) (NAMSW) FAQ

As of the most recent data (June 2026), NAMSW shows a current cash of $420M. That compares with $560M in the prior-year period — down 24.8% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, NAMSW's current cash is now $420M (was $560M) — a 24.8% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether NewAmsterdam Pharma Company NV - Warrants (15/11/2027) is outperforming or lagging.

Tracking NAMSW's current cash over time shows whether NewAmsterdam Pharma Company NV - Warrants (15/11/2027) is scaling, shrinking, or reshaping that part of the business. The current reading is $420M That compares with $560M in the prior-year period — down 24.8% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current cash page, Stockcircle has NewAmsterdam Pharma Company NV - Warrants (15/11/2027)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current cash (currently $420M) with ownership activity and broader fundamentals.